expert roundtables

Targeted Therapy for Metastatic Castration-Resistant Prostate Cancer: Organized Approach to Genomic Evaluation

by Peter R. Carroll, MD, MPH; Daniel J. George, MD; and Oliver Sartor, MD

Genomic and molecular heterogeneity is a hallmark of metastatic castration-resistant prostate cancer (mCRPC). As both genomic testing and novel sys......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles